ABCB5-TARGETING ZUR KREBSTHERAPIE

Patent europeic · EP2155248 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2155248
Numer da la dumonda
EP08742787
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-04-2008
Publitgà
24-02-2010
Concedì
10-06-2015
La protecziun finescha il pli tard
10-04-2028
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 39/395 (2006.01)
C07K 16/18 (2006.01)
Prioritad
US 923128 P 12.04.2007
US 7059 P 11.12.2007
Dumonda PCT
PCT/US2008/004715 11.04.2008
Publicaziun PCT
WO2008/127656 23.10.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  4. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  5. 10-06-2015

    Concedì

    Published in Swissreg on 10.06.2015

Partidas

Possessur

The Brigham and Women's Hospital, Inc.

75 Francis Street, Boston MA 02115, US

Inventur

FRANK, Markus, H.

Cambridge, MA 02138, US

FRANK, Natasha, Y.

Cambridge, MA 02138, US

SAYEGH, Mohamed, H.

Boston, MA 02115, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.